|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-4-20
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
In the prospective, randomized Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, implantation of paclitaxel-eluting stents (PES) safely reduced the rates of ischemic target lesion revascularization (TLR) compared with bare metal stents (BMS) in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention. Diabetes mellitus is a known predictor of adverse outcomes after percutaneous intervention in STEMI. We therefore sought to assess the impact of PES in diabetic patients with STEMI from the HORIZONS-AMI trial.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1941-7632
|
|
pubmed:author |
pubmed-author:BrodieBruce RBR,
pubmed-author:DudekDariuszD,
pubmed-author:GuagliumiGiulioG,
pubmed-author:HartmannFranzF,
pubmed-author:HoodKristin LKL,
pubmed-author:KornowskiRanR,
pubmed-author:LanskyAlexandra JAJ,
pubmed-author:MehranRoxanaR,
pubmed-author:NikolskyEugeniaE,
pubmed-author:PariseHelenH,
pubmed-author:PerugaJan ZJZ,
pubmed-author:StoneGregg WGW,
pubmed-author:WöhrleJochenJ,
pubmed-author:WitzenbichlerBernhardB
|
|
pubmed:copyrightInfo |
© 2011 American Heart Association, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
130-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21364152-Aged,
pubmed-meshheading:21364152-Angioplasty, Balloon, Coronary,
pubmed-meshheading:21364152-Diabetic Angiopathies,
pubmed-meshheading:21364152-Drug-Eluting Stents,
pubmed-meshheading:21364152-Female,
pubmed-meshheading:21364152-Humans,
pubmed-meshheading:21364152-Male,
pubmed-meshheading:21364152-Metals,
pubmed-meshheading:21364152-Middle Aged,
pubmed-meshheading:21364152-Myocardial Infarction,
pubmed-meshheading:21364152-Paclitaxel,
pubmed-meshheading:21364152-Prospective Studies,
pubmed-meshheading:21364152-Stents,
pubmed-meshheading:21364152-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
|
|
pubmed:affiliation |
Charité Campus Benjamin Franklin, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
